Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-15

FDA Approved: SYMPROIC — Supplemental Application (BioDelivery Sciences International Inc)

View source ↗

Summary

The FDA approved a supplemental application for Symproic (naldemedine) from BioDelivery Sciences International Inc, authorizing changes to the drug's labeling f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SYMPROIC (NALDEMEDINE)

Snippet

SUPPL AP for SYMPROIC (NALDEMEDINE)